as 10-17-2024 4:00pm EST
Founded: | N/A | Country: | United States |
Employees: | N/A | City: | NEW YORK |
Market Cap: | N/A | IPO Year: | N/A |
Target Price: | $48.91 | AVG Volume (30 days): | 847.2K |
Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.92 | EPS Growth: | N/A |
52 Week Low/High: | $24.67 - $45.58 | Next Earning Date: | 11-07-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Barnett Eva Renee | IMVT | Chief Financial Officer | Oct 9 '24 | Sell | $29.56 | 5,162 | $152,588.72 | 338,614 | |
Salzmann Peter | IMVT | Chief Executive Officer | Oct 9 '24 | Sell | $29.56 | 4,460 | $131,837.60 | 1,003,884 | |
Macias William L. | IMVT | Chief Medical Officer | Aug 21 '24 | Sell | $32.08 | 3,027 | $96,437.28 | 368,332 | |
Barnett Eva Renee | IMVT | Chief Financial Officer | Aug 21 '24 | Sell | $32.08 | 3,768 | $120,044.64 | 338,614 | |
Levine Mark S. | IMVT | Chief Legal Officer | Aug 21 '24 | Sell | $32.08 | 3,295 | $104,975.68 | 330,099 | |
Salzmann Peter | IMVT | Chief Executive Officer | Aug 21 '24 | Sell | $32.08 | 15,068 | $480,052.16 | 1,003,884 | |
Butchko Julia G. | IMVT | Chief Development Officer | Aug 21 '24 | Sell | $32.08 | 3,027 | $96,437.28 | 441,079 | |
Levine Mark S. | IMVT | Chief Legal Officer | Jul 24 '24 | Sell | $27.76 | 4,015 | $111,456.40 | 330,099 | |
Geffner Michael | IMVT | Chief Medical Officer | Jul 24 '24 | Sell | $27.76 | 3,456 | $95,938.56 | 138,160 | |
Stout Jay S | IMVT | Chief Technology Officer | Jul 24 '24 | Sell | $27.76 | 2,813 | $78,088.88 | 144,926 |
IMVT Breaking Stock News: Dive into IMVT Ticker-Specific Updates for Smart Investing
MT Newswires
9 days ago
Insider Monkey
17 days ago
Insider Monkey
17 days ago
MT Newswires
a month ago
Benzinga
a month ago
Pharmaceutical Technology
a month ago
Zacks
a month ago
MT Newswires
a month ago
The information presented on this page, "IMVT Immunovant Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.